Additionally, we demonstrated that the inhibition of NE in a liver metastatic mouse model significantly decreased the formation of liver metastases of CRC cells, suggesting that the inhibition of NE could be a potential therapeutic target for CRC metastasis. This evidence concerns the gene ELANE and colorectal carcinoma.